The WHO rules encourage the adoption of those technologies, presented they may be validated to show equivalent or excellent functionality when compared to regular strategies. Manufacturers seeking to employ these solutions must present sturdy validation facts to show their equivalence to pharmacopoeial methods. By completing and publishing this type, waiting for link from Forum Profiles (6)